Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Zlaket-Matta, G; Vela, BS; Brinton, EA
   The clinical relevance and management of high-density lipoprotein deficiency
   ENDOCRINOLOGIST
   
   G. Zlaket-Matta et al., "The clinical relevance and management of high-density lipoprotein deficiency", ENDOCRINOLO, 11(1), 2001, pp. 16-25
2. Wang, AYM; Sea, MMM; Ip, R; Law, MC; Chow, KM; Lui, SF; Li, PKT; Woo, J
   Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis
   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
   
   A.Y.M. Wang et al., "Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis", J AM S NEPH, 12(11), 2001, pp. 2450-2457
3. Okuno, S; Ishimura, E; Kim, M; Izumotani, T; Otoshi, T; Maekawa, K; Yamakawa, T; Morii, H; Inaba, M; Nishizawa, Y
   Changes in body fat mass in male hemodialysis patients: A comparison between diabetics and nondiabetics
   AMERICAN JOURNAL OF KIDNEY DISEASES
   
   S. Okuno et al., "Changes in body fat mass in male hemodialysis patients: A comparison between diabetics and nondiabetics", AM J KIDNEY, 38(4), 2001, pp. S208-S211
4. 
   NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy, peritoneal dialysis adequacy, vascular access, and anemia of chronic kidney disease: Update 2000
   AMERICAN JOURNAL OF KIDNEY DISEASES
   
   AM J KIDNEY, 37(1), 2001, pp. S7-S238
5. Chadha, V; Warady, BA
   What are the clinical correlates of adequate peritoneal dialysis?
   SEMINARS IN NEPHROLOGY
   
   V. Chadha e B.A. Warady, "What are the clinical correlates of adequate peritoneal dialysis?", SEM NEPHROL, 21(5), 2001, pp. 480-489
6. Kaysen, GA; Chertow, GM; Adhikarla, R; Young, B; Ronco, C; Levin, NW
   Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients
   KIDNEY INTERNATIONAL
   
   G.A. Kaysen et al., "Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients", KIDNEY INT, 60(1), 2001, pp. 333-340
7. Marsenic, O; Peco-Antic, A; Jovanovic, O
   Effect of dialysis dose on nutritional status of children on chronic hemodialysis
   NEPHRON
   
   O. Marsenic et al., "Effect of dialysis dose on nutritional status of children on chronic hemodialysis", NEPHRON, 88(3), 2001, pp. 273-275
8. Jong, MC; Rensen, PCN; Dahlmans, VEH; van der Boom, H; van Berkel, TJC; Havekes, LM
   Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice
   JOURNAL OF LIPID RESEARCH
   
   M.C. Jong et al., "Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice", J LIPID RES, 42(10), 2001, pp. 1578-1585
9. Frenais, R; Nazih, H; Ouguerram, K; Maugeais, C; Zair, Y; Bard, JM; Charbonnel, B; Magot, T; Krempf, M
   In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: A kinetic study in control subjects and patients with type II diabetes mellitus
   JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
   
   R. Frenais et al., "In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: A kinetic study in control subjects and patients with type II diabetes mellitus", J CLIN END, 86(5), 2001, pp. 1962-1967
10. Watts, GF; Barrett, PHR; Marais, AD; Dane-Stewart, CA; Martins, IJ; Dimmitt, SB; Redgrave, TG
    Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test
    ATHEROSCLEROSIS
    
    G.F. Watts et al., "Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test", ATHEROSCLER, 157(2), 2001, pp. 519-523
11. Frenais, R; Ouguerram, K; Maugeais, C; Mahot, P; Charbonnel, B; Magot, T; Krempf, M
    Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus
    ATHEROSCLEROSIS
    
    R. Frenais et al., "Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus", ATHEROSCLER, 157(1), 2001, pp. 131-135
12. Recalde, D; Velez-Carrasco, W; Civeira, F; Cenarro, A; Gomez-Coronado, D; Ordovas, JM; Pocovi, M
    Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygoussubjects for apo A-I-Zaragoza (L144R)
    ATHEROSCLEROSIS
    
    D. Recalde et al., "Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygoussubjects for apo A-I-Zaragoza (L144R)", ATHEROSCLER, 154(3), 2001, pp. 613-623
13. Kemp, HJ; Parnham, A; Tomson, CR
    Urea kinetic modelling: a measure of dialysis adequacy
    ANNALS OF CLINICAL BIOCHEMISTRY
    
    H.J. Kemp et al., "Urea kinetic modelling: a measure of dialysis adequacy", ANN CLIN BI, 38, 2001, pp. 20-27
14. Tsujita, M; Tomimoto, S; Okumura-Noji, K; Okazaki, M; Yokoyama, S
    Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
    
    M. Tsujita et al., "Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice", BBA-MOL C B, 1485(2-3), 2000, pp. 199-213
15. Elias, N; Patterson, BW; Schonfeld, G
    In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    N. Elias et al., "In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene", ART THROM V, 20(5), 2000, pp. 1309-1315
16. Velez-Carrasco, W; Lichtenstein, AH; Li, ZL; Dolnikowski, GG; Lamon-Fava, S; Welty, FK; Schaefer, EJ
    Apolipoprotein A-I and A-II kinetic parameters as assessed by endogenous labeling with [H-2(3)] leucine in middle-aged and elderly men and women
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    W. Velez-Carrasco et al., "Apolipoprotein A-I and A-II kinetic parameters as assessed by endogenous labeling with [H-2(3)] leucine in middle-aged and elderly men and women", ART THROM V, 20(3), 2000, pp. 801-806
17. Burkart, JM
    Adequacy of peritoneal dialysis
    ADVANCES IN RENAL REPLACEMENT THERAPY
    
    J.M. Burkart, "Adequacy of peritoneal dialysis", ADV RENAL R, 7(4), 2000, pp. 310-323
18. Thuren, T
    Hepatic lipase and HDL metabolism
    CURRENT OPINION IN LIPIDOLOGY
    
    T. Thuren, "Hepatic lipase and HDL metabolism", CURR OP LIP, 11(3), 2000, pp. 277-283
19. Van Hoeck, KJM; Lilien, MR; Brinkman, DC; Schroeder, CH
    Comparing a urea kinetic monitor with Daugirdas formula and dietary records in children
    PEDIATRIC NEPHROLOGY
    
    K.J.M. Van Hoeck et al., "Comparing a urea kinetic monitor with Daugirdas formula and dietary records in children", PED NEPHROL, 14(4), 2000, pp. 280-283
20. Chen, TW; Huang, TP; Wang, ML
    Significance of nitrogen removal mass in uremic patients on different modalities of dialysis therapy
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
    
    T.W. Chen et al., "Significance of nitrogen removal mass in uremic patients on different modalities of dialysis therapy", J FORMOS ME, 99(2), 2000, pp. 116-122
21. Kang, DH; Lee, R; Lee, HY; Han, DS; Cho, EY; Lee, CH; Yoon, KI
    Metabolic acidosis and composite nutritional index (CNI) in CAPD patients
    CLINICAL NEPHROLOGY
    
    D.H. Kang et al., "Metabolic acidosis and composite nutritional index (CNI) in CAPD patients", CLIN NEPHR, 53(2), 2000, pp. 124-131
22. Mak, SK; Wong, PN; Lo, KY; Tong, GMW; Fung, LH; Wong, AKM
    Randomized prospective study of the effect of increased dialytic dose on nutritional and clinical outcome in continuous ambulatory peritoneal dialysis patients
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    S.K. Mak et al., "Randomized prospective study of the effect of increased dialytic dose on nutritional and clinical outcome in continuous ambulatory peritoneal dialysis patients", AM J KIDNEY, 36(1), 2000, pp. 105-114
23. Tayeb, JS; Provenzano, R; El-Ghoroury, M; Bellovich, K; Khairullah, Q; Pieper, D; Morrison, L; Calleja, Y
    Effect of biocompatibility of hemodialysis membranes on serum albumin levels
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    J.S. Tayeb et al., "Effect of biocompatibility of hemodialysis membranes on serum albumin levels", AM J KIDNEY, 35(4), 2000, pp. 606-610
24. Garcia, H; Miguel, A; Garcia, R
    Adequate dialysis in CAPD and nutrition parameters. Mathematic or biologicrelationship?
    NEFROLOGIA
    
    H. Garcia et al., "Adequate dialysis in CAPD and nutrition parameters. Mathematic or biologicrelationship?", NEFROLOGIA, 20(6), 2000, pp. 532-539
25. Gotch, FA; Sargent, JA; Keen, ML
    Whither goest Kt/V?
    KIDNEY INTERNATIONAL
    
    F.A. Gotch et al., "Whither goest Kt/V?", KIDNEY INT, 58, 2000, pp. S3-S18
26. Canaud, B; Bosc, JY; Cabrol, L; Leray-Moragues, H; Navino, C; Verzetti, G; Thomaseth, K
    Urea as a marker of adequacy in hemodialysis: Lesson from in vivo urea dynamics monitoring
    KIDNEY INTERNATIONAL
    
    B. Canaud et al., "Urea as a marker of adequacy in hemodialysis: Lesson from in vivo urea dynamics monitoring", KIDNEY INT, 58, 2000, pp. S28-S40
27. Arrigo, G; Beltrame, A; Colasanti, G
    Adequacy in hemodialysis: New concepts derived from online urea monitoring
    KIDNEY INTERNATIONAL
    
    G. Arrigo et al., "Adequacy in hemodialysis: New concepts derived from online urea monitoring", KIDNEY INT, 58, 2000, pp. S41-S46
28. Breslow, JL
    Genetics of lipoprotein abnormalities associated with coronary heart disease susceptibility
    ANNUAL REVIEW OF GENETICS
    
    J.L. Breslow, "Genetics of lipoprotein abnormalities associated with coronary heart disease susceptibility", ANN R GENET, 34, 2000, pp. 233-254
29. Leroux, G; Lemieux, I; Lamarche, B; Cantin, B; Dagenais, GR; Lupien, PJ; Despres, JP
    Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels
    METABOLISM-CLINICAL AND EXPERIMENTAL
    
    G. Leroux et al., "Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels", METABOLISM, 49(1), 2000, pp. 53-61
30. Brousseau, ME; Eberhart, GP; Dupuis, J; Asztalos, BF; Goldkamp, AL; Schaefer, EJ; Freeman, MW
    Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size
    JOURNAL OF LIPID RESEARCH
    
    M.E. Brousseau et al., "Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size", J LIPID RES, 41(7), 2000, pp. 1125-1135
31. Asztalos, B; Lefevre, M; Wong, L; Foster, TA; Tulley, R; Windhauser, M; Zhang, WW; Roheim, PS
    Differential response to low-fat diet between low and normal HDL-cholesterol subjects
    JOURNAL OF LIPID RESEARCH
    
    B. Asztalos et al., "Differential response to low-fat diet between low and normal HDL-cholesterol subjects", J LIPID RES, 41(3), 2000, pp. 321-328
32. Qin, SC; Kawano, K; Bruce, C; Lin, M; Bisgaier, C; Tall, AR; Jiang, XC
    Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins
    JOURNAL OF LIPID RESEARCH
    
    S.C. Qin et al., "Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins", J LIPID RES, 41(2), 2000, pp. 269-276
33. Duvillard, L; Pont, F; Florentin, E; Gambert, P; Verges, B
    Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus
    ATHEROSCLEROSIS
    
    L. Duvillard et al., "Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus", ATHEROSCLER, 152(1), 2000, pp. 229-237
34. Winkler, K; Schaefer, JR; Klima, B; Nuber, C; Friedrich, I; Koster, W; Gierens, H; Scharnagl, H; Soufi, M; Wieland, H; Marz, W
    HDL steady state levels are not affected, but HDL apoA-I turnover is enhanced by Lifibrol in patients with hypercholesterolemia and mixed hyperlipidemia
    ATHEROSCLEROSIS
    
    K. Winkler et al., "HDL steady state levels are not affected, but HDL apoA-I turnover is enhanced by Lifibrol in patients with hypercholesterolemia and mixed hyperlipidemia", ATHEROSCLER, 150(1), 2000, pp. 113-120
35. Lopez-Miranda, J; Marin, C; Castro, P; Gomez, F; Gonzalez-Amieva, A; Paz, E; Bravo, D; Ordovas, JM; Jimenez-Pereperez, J; Perez-Jimenez, F
    The effect of apolipoprotein B xbal polymorphism on plasma lipid response to dietary fat
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    
    J. Lopez-Miranda et al., "The effect of apolipoprotein B xbal polymorphism on plasma lipid response to dietary fat", EUR J CL IN, 30(8), 2000, pp. 678-684
36. Nanjee, MN; Brinton, EA
    Very small apolipoprotein A-I-containing particles from human plasma: Isolation and quantification by high-performance size-exclusion chromatography
    CLINICAL CHEMISTRY
    
    M.N. Nanjee e E.A. Brinton, "Very small apolipoprotein A-I-containing particles from human plasma: Isolation and quantification by high-performance size-exclusion chromatography", CLIN CHEM, 46(2), 2000, pp. 207-223
37. Kobayashi, J; Murano, S; Yokote, K; Mori, S; Matsunaga, A; Sasaki, J; Takahashi, K; Bujo, H; Saito, Y
    Marked decrease in plasma apolipoprotein A-I and high density lipoprotein-cholesterol in a case with Werner syndrome
    CLINICA CHIMICA ACTA
    
    J. Kobayashi et al., "Marked decrease in plasma apolipoprotein A-I and high density lipoprotein-cholesterol in a case with Werner syndrome", CLIN CHIM A, 293(1-2), 2000, pp. 63-73
38. Silva, ERDE; Foster, D; Harper, MM; Seidman, CE; Smith, JD; Breslow, JL; Brinton, EA
    Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II
    CIRCULATION
    
    E.R.D.E. Silva et al., "Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II", CIRCULATION, 102(19), 2000, pp. 2347-2352
39. Sanchez-Muniz, FJ; Bastida, S; Viejo, JM; Terpstra, AHM
    Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholipid and apolipoprotein B concentrations in young adult women
    EUROPEAN JOURNAL OF NUTRITION
    
    F.J. Sanchez-Muniz et al., "Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholipid and apolipoprotein B concentrations in young adult women", EUR J NUTR, 38(1), 1999, pp. 20-27
40. Plump, AS; Masucci-Magoulas, L; Bruce, C; Bisgaier, CL; Breslow, JL; Tall, AR
    Increased atherosclerosis in apoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    A.S. Plump et al., "Increased atherosclerosis in apoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression", ART THROM V, 19(4), 1999, pp. 1105-1110
41. Jong, MC; Hofker, MH; Havekes, LM
    Role of ApoCs in lipoprotein metabolism - Functional differences between ApoC1, ApoC2, and ApoC3
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    M.C. Jong et al., "Role of ApoCs in lipoprotein metabolism - Functional differences between ApoC1, ApoC2, and ApoC3", ART THROM V, 19(3), 1999, pp. 472-484
42. Kloppenburg, WD; Stegeman, CA; de Jong, PE; Huisman, RM
    Relating protein intake to nutritional status in haemodialysis patients: how to normalize the protein equivalent of total nitrogen appearance (PNA)?
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    W.D. Kloppenburg et al., "Relating protein intake to nutritional status in haemodialysis patients: how to normalize the protein equivalent of total nitrogen appearance (PNA)?", NEPH DIAL T, 14(9), 1999, pp. 2165-2172
43. Caravaca, F; Arrobas, M; Dominguez, C
    Influence of residual renal function on dietary protein and caloric intakein patients on incremental peritoneal dialysis
    PERITONEAL DIALYSIS INTERNATIONAL
    
    F. Caravaca et al., "Influence of residual renal function on dietary protein and caloric intakein patients on incremental peritoneal dialysis", PERIT DIA I, 19(4), 1999, pp. 350-356
44. Canaud, B; Bosc, JY; Vaussenat, F; Leray-Moragues, H; Leblanc, M; Garred, LJ; Mion, C
    Quantitation in hemodialysis: Adequacy measurement revisited
    SEMINARS IN DIALYSIS
    
    B. Canaud et al., "Quantitation in hemodialysis: Adequacy measurement revisited", SEMIN DIAL, 12(5), 1999, pp. 370-375
45. Greene, T; Depner, TA; Daugirdas, JT
    Mathematical coupling and the association between Kt/V and PCRn
    SEMINARS IN DIALYSIS
    
    T. Greene et al., "Mathematical coupling and the association between Kt/V and PCRn", SEMIN DIAL, 12, 1999, pp. S20-S28
46. Movilli, E
    Adequacy, nutrition, and biocompatibility: Their relevance on clinical outcome in haemodialysis patients
    BLOOD PURIFICATION
    
    E. Movilli, "Adequacy, nutrition, and biocompatibility: Their relevance on clinical outcome in haemodialysis patients", BLOOD PURIF, 17(2-3), 1999, pp. 159-165
47. Kloppenburg, WD; Stegeman, CA; Hooyschuur, M; van der Ven, J; de Jong, PE; Huisman, RM
    Assessing dialysis adequacy and dietary intake in the individual hemodialysis patient
    KIDNEY INTERNATIONAL
    
    W.D. Kloppenburg et al., "Assessing dialysis adequacy and dietary intake in the individual hemodialysis patient", KIDNEY INT, 55(5), 1999, pp. 1961-1969
48. Oreopoulos, DG; Madias, NE; Harrington, JT; Perrone, RD; Narayan, G; Singh, AK; Bunnapradist, S
    The optimization of continuous ambulatory peritoneal dialysis
    KIDNEY INTERNATIONAL
    
    D.G. Oreopoulos et al., "The optimization of continuous ambulatory peritoneal dialysis", KIDNEY INT, 55(3), 1999, pp. 1131-1149
49. Silva, ERDE; Kong, M; Han, ZH; Starr, C; Kass, EM; Juo, SHH; Foster, D; Dansky, HM; Merkel, M; Cundey, K; Brinton, EA; Breslow, JL; Smith, JD
    Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females
    JOURNAL OF LIPID RESEARCH
    
    E.R.D.E. Silva et al., "Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females", J LIPID RES, 40(7), 1999, pp. 1211-1221
50. Weng, W; Brandenburg, NA; Zhong, SB; Halkias, J; Wu, L; Jiang, XC; Tall, A; Breslow, JL
    ApoA-II maintains HDL levels in part by inhibition of hepatic lipase: studies in apoA-II and hepatic lipase double knockout mice
    JOURNAL OF LIPID RESEARCH
    
    W. Weng et al., "ApoA-II maintains HDL levels in part by inhibition of hepatic lipase: studies in apoA-II and hepatic lipase double knockout mice", J LIPID RES, 40(6), 1999, pp. 1064-1070
51. Hosoai, H; Webb, NR; Glick, JM; Tietge, UJF; Purdom, MS; de Beer, FC; Rader, DJ
    Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice
    JOURNAL OF LIPID RESEARCH
    
    H. Hosoai et al., "Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice", J LIPID RES, 40(4), 1999, pp. 648-653
52. Jauhiainen, M; Huuskonen, J; Baumann, M; Metso, J; Oka, T; Egashira, T; Hattori, H; Olkkonen, VM; Ehnholm, C
    Phospholipid transfer protein (PLTP) causes proteolytic cleavage of apolipoprotein A-I
    JOURNAL OF LIPID RESEARCH
    
    M. Jauhiainen et al., "Phospholipid transfer protein (PLTP) causes proteolytic cleavage of apolipoprotein A-I", J LIPID RES, 40(4), 1999, pp. 654-664
53. Braschi, S; Neville, TAM; Vohl, MC; Sparks, DL
    Apolipoprotein A-I charge and conformation regulate the clearance of reconstituted high density lipoprotein in vivo
    JOURNAL OF LIPID RESEARCH
    
    S. Braschi et al., "Apolipoprotein A-I charge and conformation regulate the clearance of reconstituted high density lipoprotein in vivo", J LIPID RES, 40(3), 1999, pp. 522-532
54. Lamarche, B; Uffelman, KD; Carpentier, A; Cohn, JS; Steiner, G; Barrett, PH; Lewis, GF
    Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDLapo A-I in healthy men
    JOURNAL OF CLINICAL INVESTIGATION
    
    B. Lamarche et al., "Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDLapo A-I in healthy men", J CLIN INV, 103(8), 1999, pp. 1191-1199
55. Suzuki, H; Aoki, T; Tamaki, T; Sato, F; Kitahara, M; Saito, Y
    Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs
    ATHEROSCLEROSIS
    
    H. Suzuki et al., "Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs", ATHEROSCLER, 146(2), 1999, pp. 259-270
56. Korhonen, T; Savolainen, MJ; Kesaniemi, YA
    Variation of apolipoprotein B as a possible cause of decreased low densitylipoprotein clearance and hypercholesterolemia
    ATHEROSCLEROSIS
    
    T. Korhonen et al., "Variation of apolipoprotein B as a possible cause of decreased low densitylipoprotein clearance and hypercholesterolemia", ATHEROSCLER, 146(1), 1999, pp. 1-10
57. Gottrand, F; Beghin, L; Duhal, N; Lacroix, B; Bonte, JP; Fruchart, JC; Luc, G
    Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    
    F. Gottrand et al., "Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII", EUR J CL IN, 29(5), 1999, pp. 387-394
58. Werynski, A; Nahorski, Z; Berglund, L; Ericsson, S; Angelin, B; Eriksson, M
    Evidence of circadian rhythm in low-density lipoprotein apoB catabolism and its impact on the estimation of kinetic parameters
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    
    A. Werynski et al., "Evidence of circadian rhythm in low-density lipoprotein apoB catabolism and its impact on the estimation of kinetic parameters", EUR J CL IN, 29(4), 1999, pp. 291-300
59. Saku, K; von Eckardstein, A; Zhang, B; Liu, R; Jimi, S; Ou, J; Ohta, T; Assmann, G; Arakawa, K
    In vivo kinetics of human apolipoprotein A-I variants in rabbits
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    
    K. Saku et al., "In vivo kinetics of human apolipoprotein A-I variants in rabbits", EUR J CL IN, 29(3), 1999, pp. 196-203
60. Brites, FD; Cavallero, E; de Geitere, C; Nicolaiew, N; Jacotot, B; Rosseneu, M; Fruchart, JC; Wikinski, RL; Castro, GR
    Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients
    CLINICA CHIMICA ACTA
    
    F.D. Brites et al., "Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients", CLIN CHIM A, 279(1-2), 1999, pp. 1-14
61. BATAL R; TREMBLAY M; KRIMBOU L; MAMER O; DAVIGNON J; GENEST J; COHN JS
    FAMILIAL HDL DEFICIENCY CHARACTERIZED BY HYPERCATABOLISM OF MATURE APOA-I BUT NOT PROAPOA-I
    Arteriosclerosis, thrombosis, and vascular biology
    
    R. Batal et al., "FAMILIAL HDL DEFICIENCY CHARACTERIZED BY HYPERCATABOLISM OF MATURE APOA-I BUT NOT PROAPOA-I", Arteriosclerosis, thrombosis, and vascular biology, 18(4), 1998, pp. 655-664
62. CANAUD B; BOSC JY; LEBLANC M; VAUSSENAT F; LERAYMORAGUES H; GARRED LJ; MATHIEUDAUDE JC; MION G
    ONLINE DIALYSIS QUANTIFICATION IN ACUTELY ILL PATIENTS - PRELIMINARY CLINICAL-EXPERIENCE WITH A MULTIPURPOSE UREA SENSOR MONITORING DEVICE
    ASAIO journal
    
    B. Canaud et al., "ONLINE DIALYSIS QUANTIFICATION IN ACUTELY ILL PATIENTS - PRELIMINARY CLINICAL-EXPERIENCE WITH A MULTIPURPOSE UREA SENSOR MONITORING DEVICE", ASAIO journal, 44(3), 1998, pp. 184-190
63. MOVILLI E; ZANI R; CARLI O; SANGALLI L; POLA A; CAMERINI C; CANCARINI GC; SCOLARI F; FELLER P; MAIORCA R
    CORRECTION OF METABOLIC-ACIDOSIS INCREASES SERUM-ALBUMIN CONCENTRATIONS AND DECREASES KINETICALLY EVALUATED PROTEIN-INTAKE IN HEMODIALYSIS-PATIENTS - A PROSPECTIVE-STUDY
    Nephrology, dialysis, transplantation
    
    E. Movilli et al., "CORRECTION OF METABOLIC-ACIDOSIS INCREASES SERUM-ALBUMIN CONCENTRATIONS AND DECREASES KINETICALLY EVALUATED PROTEIN-INTAKE IN HEMODIALYSIS-PATIENTS - A PROSPECTIVE-STUDY", Nephrology, dialysis, transplantation, 13(7), 1998, pp. 1719-1722
64. MOVILLI E; BOSSINI N; VIOLA BF; CAMERINI C; CANCARINI GC; FELLER P; STRADA A; MAIORCA R
    EVIDENCE FOR AN INDEPENDENT ROLE OF METABOLIC-ACIDOSIS ON NUTRITIONAL-STATUS IN HEMODIALYSIS-PATIENTS
    Nephrology, dialysis, transplantation
    
    E. Movilli et al., "EVIDENCE FOR AN INDEPENDENT ROLE OF METABOLIC-ACIDOSIS ON NUTRITIONAL-STATUS IN HEMODIALYSIS-PATIENTS", Nephrology, dialysis, transplantation, 13(3), 1998, pp. 674-678
65. MAMOUN AH
    ANOREXIA IN PATIENTS WITH CHRONIC-RENAL-FAILURE - PROGRESS TOWARDS UNDERSTANDING THE MOLECULAR-BASIS
    Nephrology, dialysis, transplantation
    
    A.H. Mamoun, "ANOREXIA IN PATIENTS WITH CHRONIC-RENAL-FAILURE - PROGRESS TOWARDS UNDERSTANDING THE MOLECULAR-BASIS", Nephrology, dialysis, transplantation, 13(10), 1998, pp. 2460-2463
66. JONES CH
    IS SERUM-ALBUMIN A USEFUL MEASURE OF NUTRITIONAL-STATUS IN DIALYSIS PATIENTS
    Seminars in dialysis
    
    C.H. Jones, "IS SERUM-ALBUMIN A USEFUL MEASURE OF NUTRITIONAL-STATUS IN DIALYSIS PATIENTS", Seminars in dialysis, 11(3), 1998, pp. 144-147
67. RAJ DSC; TOBE SW; SAIPHOO CS; MANUEL MA
    MASS-BALANCE INDEX - AN INDEX FOR ADEQUACY OF DIALYSIS AND NUTRITION
    International journal of artificial organs
    
    D.S.C. Raj et al., "MASS-BALANCE INDEX - AN INDEX FOR ADEQUACY OF DIALYSIS AND NUTRITION", International journal of artificial organs, 21(6), 1998, pp. 328-334
68. KAYSEN GA
    ALBUMIN TURNOVER IN RENAL-DISEASE
    Mineral and electrolyte metabolism
    
    G.A. Kaysen, "ALBUMIN TURNOVER IN RENAL-DISEASE", Mineral and electrolyte metabolism, 24(1), 1998, pp. 55-63
69. OWEN WF
    NUTRITIONAL-STATUS AND SURVIVAL IN END-STAGE RENAL-DISEASE PATIENTS
    Mineral and electrolyte metabolism
    
    W.F. Owen, "NUTRITIONAL-STATUS AND SURVIVAL IN END-STAGE RENAL-DISEASE PATIENTS", Mineral and electrolyte metabolism, 24(1), 1998, pp. 72-81
70. BASTIDA S; PEREA S; SANCHEZMUNIZ FJ
    DO NEONATES WITH HIGH SERUM-CHOLESTEROL LEVELS HAVE A DIFFERENT HIGH-DENSITY-LIPOPROTEIN COMPOSITION
    European journal of pediatrics
    
    S. Bastida et al., "DO NEONATES WITH HIGH SERUM-CHOLESTEROL LEVELS HAVE A DIFFERENT HIGH-DENSITY-LIPOPROTEIN COMPOSITION", European journal of pediatrics, 157(1), 1998, pp. 66-70
71. CANAUD B; BOSC JY; LEBLANC M; GARRED LJ; VO T; MION C
    EVALUATION OF HIGH-FLUX HEMODIAFILTRATION EFFICIENCY USING AN ONLINE UREA MONITOR
    American journal of kidney diseases
    
    B. Canaud et al., "EVALUATION OF HIGH-FLUX HEMODIAFILTRATION EFFICIENCY USING AN ONLINE UREA MONITOR", American journal of kidney diseases, 31(1), 1998, pp. 74-80
72. JEAN G; CHAZOT C; CHARRA B; TERRAT B; TERRAT JC; VANEL T; CALEMARD E; LAURENT G
    IS POSTDIALYSIS UREA REBOUND SIGNIFICANT WITH LONG SLOW HEMODIALYSIS
    Blood purification
    
    G. Jean et al., "IS POSTDIALYSIS UREA REBOUND SIGNIFICANT WITH LONG SLOW HEMODIALYSIS", Blood purification, 16(4), 1998, pp. 187-196
73. SOBH MA; SHEASHAA H; TANTAWY AE; GHONEIM MA
    STUDY OF EFFECT OF OPTIMIZATION OF DIALYSIS AND PROTEIN INTAKE ON NEUROMUSCULAR FUNCTION PATIENTS UNDER MAINTENANCE HEMODIALYSIS-TREATMENT
    American journal of nephrology
    
    M.A. Sobh et al., "STUDY OF EFFECT OF OPTIMIZATION OF DIALYSIS AND PROTEIN INTAKE ON NEUROMUSCULAR FUNCTION PATIENTS UNDER MAINTENANCE HEMODIALYSIS-TREATMENT", American journal of nephrology, 18(5), 1998, pp. 399-403
74. CANO N; STROUMZA P
    MANAGEMENT OF DENUTRITION IN CHRONIC HEMODIALYZED PATIENTS
    Nephrologie (Geneve)
    
    N. Cano e P. Stroumza, "MANAGEMENT OF DENUTRITION IN CHRONIC HEMODIALYZED PATIENTS", Nephrologie (Geneve), 19(6), 1998, pp. 353-357
75. CANAUD B; LEBLANC M; LERAYMORAGUES H; DELMAS S; KLOUCHE K; VELA C; BERAUD JJ
    ACUTE-RENAL-FAILURE - NUTRITIONAL DISORDE RS AND THERAPEUTIC IMPLICATIONS
    Nephrologie
    
    B. Canaud et al., "ACUTE-RENAL-FAILURE - NUTRITIONAL DISORDE RS AND THERAPEUTIC IMPLICATIONS", Nephrologie, 19(2), 1998, pp. 75-81
76. CONTIERO E; FERRARI R; VASELLI GM; FOLIN M
    QUANTIFICATION OF APOLIPOPROTEIN AI-CONTAINING LIPOPROTEIN PARTICLES IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    Diabetes research and clinical practice
    
    E. Contiero et al., "QUANTIFICATION OF APOLIPOPROTEIN AI-CONTAINING LIPOPROTEIN PARTICLES IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS", Diabetes research and clinical practice, 39(3), 1998, pp. 201-209
77. QURESHI AR; ALVESTRAND A; DANIELSSON A; DIVINO JC; GUTIERREZ A; LINDHOLM B; BERGSTROM J
    FACTORS PREDICTING MALNUTRITION IN HEMODIALYSIS-PATIENTS - A CROSS-SECTIONAL STUDY
    Kidney international
    
    A.R. Qureshi et al., "FACTORS PREDICTING MALNUTRITION IN HEMODIALYSIS-PATIENTS - A CROSS-SECTIONAL STUDY", Kidney international, 53(3), 1998, pp. 773-782
78. STEVENSON RT; GREENE S; KAYSEN GA
    SERUM ALPHA-2-MACROGLOBULIN AND ALPHA-1-INHIBITOR-3 CONCENTRATIONS ARE INCREASED IN HYPOALBUMINEMIA BY POSTTRANSCRIPTIONAL MECHANISMS
    Kidney international
    
    R.T. Stevenson et al., "SERUM ALPHA-2-MACROGLOBULIN AND ALPHA-1-INHIBITOR-3 CONCENTRATIONS ARE INCREASED IN HYPOALBUMINEMIA BY POSTTRANSCRIPTIONAL MECHANISMS", Kidney international, 53(1), 1998, pp. 67-75
79. LEWIS GF; UFFELMAN KD; LAMARCHE B; CABANA VG; GETZ GS
    PRODUCTION OF SMALL HIGH-DENSITY-LIPOPROTEIN PARTICLES AFTER STIMULATION OF IN-VIVO LIPOLYSIS IN HYPERTRIGLYCERIDEMIC INDIVIDUAL - STUDIES BEFORE AND AFTER TRIGLYCERIDE-LOWERING THERAPY
    Metabolism, clinical and experimental
    
    G.F. Lewis et al., "PRODUCTION OF SMALL HIGH-DENSITY-LIPOPROTEIN PARTICLES AFTER STIMULATION OF IN-VIVO LIPOLYSIS IN HYPERTRIGLYCERIDEMIC INDIVIDUAL - STUDIES BEFORE AND AFTER TRIGLYCERIDE-LOWERING THERAPY", Metabolism, clinical and experimental, 47(2), 1998, pp. 234-242
80. BROUSSEAU ME; WANG J; DEMOSKY SJ; VAISMAN BL; TALLEY GD; SANTAMARINAFOJO S; BREWER HB; HOEG JM
    CORRECTION OF HYPOALPHALIPOPROTEINEMIA IN LDL RECEPTOR-DEFICIENT RABBITS BY LECITHIN-CHOLESTEROL ACYLTRANSFERASE
    Journal of lipid research
    
    M.E. Brousseau et al., "CORRECTION OF HYPOALPHALIPOPROTEINEMIA IN LDL RECEPTOR-DEFICIENT RABBITS BY LECITHIN-CHOLESTEROL ACYLTRANSFERASE", Journal of lipid research, 39(8), 1998, pp. 1558-1567
81. LAMARCHE B; UFFELMAN KD; STEINER G; BARRETT PHR; LEWIS GF
    ANALYSIS OF PARTICLE-SIZE AND LIPID-COMPOSITION AS DETERMINANTS OF THE METABOLIC-CLEARANCE OF HUMAN HIGH-DENSITY-LIPOPROTEINS IN A RABBIT MODEL
    Journal of lipid research
    
    B. Lamarche et al., "ANALYSIS OF PARTICLE-SIZE AND LIPID-COMPOSITION AS DETERMINANTS OF THE METABOLIC-CLEARANCE OF HUMAN HIGH-DENSITY-LIPOPROTEINS IN A RABBIT MODEL", Journal of lipid research, 39(6), 1998, pp. 1162-1172
82. NAKA Y; YOSHINO G; HIRANO T; MURATA Y; MAEDA E; KAZUMI T; KASUGA M
    TRIGLYCERIDE-METABOLISM IN HETEROZYGOTE OF WATANABE HERITABLE HYPERLIPIDEMIC RABBIT
    Atherosclerosis
    
    Y. Naka et al., "TRIGLYCERIDE-METABOLISM IN HETEROZYGOTE OF WATANABE HERITABLE HYPERLIPIDEMIC RABBIT", Atherosclerosis, 136(2), 1998, pp. 325-332
83. TILLYKIESI M; LICHTENSTEIN AH; JOVEN J; VILELLA E; CHEUNG MC; CARRASCO WV; ORDOVAS JM; DOLNIKOWSKI G; SCHAEFER EJ
    IMPACT OF GENDER ON THE METABOLISM OF APOLIPOPROTEIN-A-I IN HDL SUBCLASSES LPAI AND LPAI-AII IN OLDER SUBJECTS
    Arteriosclerosis, thrombosis, and vascular biology
    
    M. Tillykiesi et al., "IMPACT OF GENDER ON THE METABOLISM OF APOLIPOPROTEIN-A-I IN HDL SUBCLASSES LPAI AND LPAI-AII IN OLDER SUBJECTS", Arteriosclerosis, thrombosis, and vascular biology, 17(12), 1997, pp. 3513-3518
84. ASZTALOS BF; LEFEVRE M; FOSTER TA; TULLEY R; WINDHAUSER M; WONG L; ROHEIM PS
    NORMOLIPIDEMIC SUBJECTS WITH LOW HDL CHOLESTEROL LEVELS HAVE ALTERED HDL SUBPOPULATIONS
    Arteriosclerosis, thrombosis, and vascular biology
    
    B.F. Asztalos et al., "NORMOLIPIDEMIC SUBJECTS WITH LOW HDL CHOLESTEROL LEVELS HAVE ALTERED HDL SUBPOPULATIONS", Arteriosclerosis, thrombosis, and vascular biology, 17(10), 1997, pp. 1885-1893
85. CUCHEL M; SCHAEFER EJ; MILLAR JS; JONES PJH; DOLNIKOWSKI GG; VERGANI C; LICHTENSTEIN AH
    LOVASTATIN DECREASES DE-NOVO CHOLESTEROL-SYNTHESIS AND LDL APO B-100 PRODUCTION-RATES IN COMBINED-HYPERLIPIDEMIC MALES
    Arteriosclerosis, thrombosis, and vascular biology
    
    M. Cuchel et al., "LOVASTATIN DECREASES DE-NOVO CHOLESTEROL-SYNTHESIS AND LDL APO B-100 PRODUCTION-RATES IN COMBINED-HYPERLIPIDEMIC MALES", Arteriosclerosis, thrombosis, and vascular biology, 17(10), 1997, pp. 1910-1917
86. TATO F; VEGA GL; GRUNDY SM
    DETERMINANTS OF PLASMA HDL-CHOLESTEROL IN HYPERTRIGLYCERIDEMIC PATIENTS - ROLE OF CHOLESTEROL-ESTER TRANSFER PROTEIN AND LECITHIN CHOLESTERYL ACYL TRANSFERASE
    Arteriosclerosis, thrombosis, and vascular biology
    
    F. Tato et al., "DETERMINANTS OF PLASMA HDL-CHOLESTEROL IN HYPERTRIGLYCERIDEMIC PATIENTS - ROLE OF CHOLESTEROL-ESTER TRANSFER PROTEIN AND LECITHIN CHOLESTERYL ACYL TRANSFERASE", Arteriosclerosis, thrombosis, and vascular biology, 17(1), 1997, pp. 56-63
87. MEHROTRA R; SARAN R; NOLPH KD; MOORE HL; KHANNA R
    EVIDENCE THAT UREA IS A BETTER SURROGATE MARKER OF UREMIC TOXICITY THAN CREATININE
    ASAIO journal
    
    R. Mehrotra et al., "EVIDENCE THAT UREA IS A BETTER SURROGATE MARKER OF UREMIC TOXICITY THAN CREATININE", ASAIO journal, 43(5), 1997, pp. 858-861
88. JONES CH; NEWSTEAD CG; WILL EJ; SMYE SW; DAVISON AM
    ASSESSMENT OF NUTRITIONAL-STATUS IN CAPD PATIENTS - SERUM-ALBUMIN IS NOT A USEFUL MEASURE
    Nephrology, dialysis, transplantation
    
    C.H. Jones et al., "ASSESSMENT OF NUTRITIONAL-STATUS IN CAPD PATIENTS - SERUM-ALBUMIN IS NOT A USEFUL MEASURE", Nephrology, dialysis, transplantation, 12(7), 1997, pp. 1406-1413
89. SHINZATO T; NAKAI S; AKIBA T; YAMAZAKI C; SASAKI R; KITAOKA T; KUBO K; SHINODA T; KUROKAWA K; MARUMO F; SATO T; MAEDA K
    SURVIVAL IN LONG-TERM HEMODIALYSIS-PATIENTS - RESULTS FROM THE ANNUALSURVEY OF THE JAPANESE-SOCIETY-FOR-DIALYSIS-THERAPY (VOL 11, PG 2139,1996)
    Nephrology, dialysis, transplantation
    
    T. Shinzato et al., "SURVIVAL IN LONG-TERM HEMODIALYSIS-PATIENTS - RESULTS FROM THE ANNUALSURVEY OF THE JAPANESE-SOCIETY-FOR-DIALYSIS-THERAPY (VOL 11, PG 2139,1996)", Nephrology, dialysis, transplantation, 12(5), 1997, pp. 884-888
90. GARRED LJ; CANAUD B; BOSC JY; TETTA C
    UREA REBOUND AND DELIVERED KT V DETERMINATION WITH A CONTINUOUS UREA SENSOR/
    Nephrology, dialysis, transplantation
    
    L.J. Garred et al., "UREA REBOUND AND DELIVERED KT V DETERMINATION WITH A CONTINUOUS UREA SENSOR/", Nephrology, dialysis, transplantation, 12(3), 1997, pp. 535-542
91. WILLIAMS AJ; DITTMER ID; MCARLEY A; CLARKE J
    HIGH BICARBONATE DIALYSATE IN HEMODIALYSIS-PATIENTS - EFFECTS ON ACIDOSIS AND NUTRITIONAL-STATUS
    Nephrology, dialysis, transplantation
    
    A.J. Williams et al., "HIGH BICARBONATE DIALYSATE IN HEMODIALYSIS-PATIENTS - EFFECTS ON ACIDOSIS AND NUTRITIONAL-STATUS", Nephrology, dialysis, transplantation, 12(12), 1997, pp. 2633-2637
92. MARCEN R; TERUEL JL; DELACAL MA; GAMEZ C; CARAMELO J; HERRERO JA; HERNANDEZ E; DEARRIBAS G; JARILLO MD; MONTOYO C; REVUELTA KL; PEREZ R; MARTINEZ J; MIGUEL JL; NAYA M; SANZ P; SANCHEZ A; CAPARROS L; CHACON JC; PARAISO V; OLIET A; VIGIL A; SANZ R; TORNERO F; LOZANO L; DIAZ R; VAZQUEZ I; RUIZ; LAMAS S; NARANJO J; HERNANDO P
    THE IMPACT OF MALNUTRITION IN MORBIDITY AND MORTALITY IN STABLE HEMODIALYSIS-PATIENTS
    Nephrology, dialysis, transplantation
    
    R. Marcen et al., "THE IMPACT OF MALNUTRITION IN MORBIDITY AND MORTALITY IN STABLE HEMODIALYSIS-PATIENTS", Nephrology, dialysis, transplantation, 12(11), 1997, pp. 2324-2331
93. DASGUPTA M; TWARDOWSKI Z; VAS S; BURKART J; GRZEGORZEWSKA A
    MONOARTHRITIS IN A PATIENT WITH LUPUS NEPHRITIS ON PERITONEAL-DIALYSIS
    Peritoneal dialysis international
    
    M. Dasgupta et al., "MONOARTHRITIS IN A PATIENT WITH LUPUS NEPHRITIS ON PERITONEAL-DIALYSIS", Peritoneal dialysis international, 17(6), 1997, pp. 619-629
94. BLAKE PG
    THE PROBLEM OF MATHEMATICAL COUPLING - HOW CAN STATISTICAL ARTIFACT AND BIOLOGICAL CAUSATION BE SEPARATED WHEN RELATING PROTEIN-INTAKE TO CLEARANCE IN PREDIALYSIS AND DIALYSIS PATIENTS
    Peritoneal dialysis international
    
    P.G. Blake, "THE PROBLEM OF MATHEMATICAL COUPLING - HOW CAN STATISTICAL ARTIFACT AND BIOLOGICAL CAUSATION BE SEPARATED WHEN RELATING PROTEIN-INTAKE TO CLEARANCE IN PREDIALYSIS AND DIALYSIS PATIENTS", Peritoneal dialysis international, 17(5), 1997, pp. 431-434
95. GOKAL R
    ADEQUACY, NUTRITION AND OUTCOME IN PERITONEAL-DIALYSIS - IS THERE A LINK
    Seminars in dialysis
    
    R. Gokal, "ADEQUACY, NUTRITION AND OUTCOME IN PERITONEAL-DIALYSIS - IS THERE A LINK", Seminars in dialysis, 10(2), 1997, pp. 94-99
96. URIBARRI J
    MODERATE METABOLIC-ACIDOSIS AND ITS EFFECTS ON NUTRITIONAL PARAMETERSIN HEMODIALYSIS-PATIENTS
    Clinical nephrology
    
    J. Uribarri, "MODERATE METABOLIC-ACIDOSIS AND ITS EFFECTS ON NUTRITIONAL PARAMETERSIN HEMODIALYSIS-PATIENTS", Clinical nephrology, 48(4), 1997, pp. 238-240
97. BALTZAN MA; SHOKER AS; BALTZAN RB
    PROTEIN-MALNUTRITION AND DECREASED PROTEIN-TURNOVER IN CHRONIC RENAL-ALLOGRAFT FAILURE
    Clinical nephrology
    
    M.A. Baltzan et al., "PROTEIN-MALNUTRITION AND DECREASED PROTEIN-TURNOVER IN CHRONIC RENAL-ALLOGRAFT FAILURE", Clinical nephrology, 47(2), 1997, pp. 112-116
98. EKNOYAN G; LEVIN NW; OWEN W; ROBERTS J; ALEXANDER S; COHEN D; HARMON W; ING T; KARI J; KEEN M; KING K; LETTERI J; TEEHAN B; TZAMALOUKAS A; WARADY B
    NKF-DOQI CLINICAL-PRACTICE GUIDELINES FOR HEMODIALYSIS ADEQUACY
    American journal of kidney diseases
    
    G. Eknoyan et al., "NKF-DOQI CLINICAL-PRACTICE GUIDELINES FOR HEMODIALYSIS ADEQUACY", American journal of kidney diseases, 30(3), 1997, pp. 17-63
99. EKNOYAN G; LEVIN NW; OWEN W; ROBERTS J; ALEXANDER S; COHEN D; HARMON W; ING T; KARI J; KEEN M; KING K; LETTERI J; TEEHAN B; TZAMALOUKAS A; WARADY B
    NKF-DOQI CLINICAL-PRACTICE GUIDELINES FOR PERITONEAL-DIALYSIS ADEQUACY
    American journal of kidney diseases
    
    G. Eknoyan et al., "NKF-DOQI CLINICAL-PRACTICE GUIDELINES FOR PERITONEAL-DIALYSIS ADEQUACY", American journal of kidney diseases, 30(3), 1997, pp. 69-133
100. RAJ DSC; LANGOS V; GANGAM N; ROSCOE J
     ETHNIC VARIABILITY IN PERITONEAL EQUILIBRATION TEST AND UREA KINETICS
     American journal of kidney diseases
     
     D.S.C. Raj et al., "ETHNIC VARIABILITY IN PERITONEAL EQUILIBRATION TEST AND UREA KINETICS", American journal of kidney diseases, 30(3), 1997, pp. 374-381